Champlain Investment Partners’s Cardiovascular Systems, Inc. CSII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,301,475
| Closed | -$45.7M | – | 132 |
|
|
2023
Q1 | $45.7M | Sell |
2,301,475
-36,610
| -2% | -$632K | 0.29% | 111 |
|
|
2022
Q4 | $31.8M | Sell |
2,338,085
-81,140
| -3% | -$1.13M | 0.2% | 121 |
|
|
2022
Q3 | $33.5M | Sell |
2,419,225
-43,490
| -2% | -$646K | 0.23% | 119 |
|
|
2022
Q2 | $35.4M | Sell |
2,462,715
-1,023,620
| -29% | -$17.8M | 0.23% | 118 |
|
|
2022
Q1 | $78.8M | Sell |
3,486,335
-2,290
| -0.1% | -$44.4K | 0.41% | 96 |
|
|
2021
Q4 | $65.5M | Buy |
3,488,625
+167,105
| +5% | +$4.46M | 0.3% | 112 |
|
|
2021
Q3 | $109M | Sell |
3,321,520
-112,665
| -3% | -$4.2M | 0.52% | 89 |
|
|
2021
Q2 | $146M | Sell |
3,434,185
-15,445
| -0.4% | -$604K | 0.7% | 59 |
|
|
2021
Q1 | $132M | Buy |
3,449,630
+378,460
| +12% | +$16.1M | 0.69% | 67 |
|
|
2020
Q4 | $134M | Buy |
3,071,170
+109,980
| +4% | +$4.14M | 0.77% | 57 |
|
|
2020
Q3 | $117M | Buy |
2,961,190
+24,000
| +0.8% | +$775K | 0.79% | 53 |
|
|
2020
Q2 | $92.7M | Buy |
2,937,190
+246,780
| +9% | +$9.22M | 0.67% | 59 |
|
|
2020
Q1 | $94.7M | Buy |
2,690,410
+292,215
| +12% | +$12.3M | 0.85% | 44 |
|
|
2019
Q4 | $117M | Buy |
2,398,195
+470,615
| +24% | +$21.4M | 0.85% | 50 |
|
|
2019
Q3 | $91.6M | Sell |
1,927,580
-246,730
| -11% | -$11.6M | 0.75% | 58 |
|
|
2019
Q2 | $93.3M | Buy |
2,174,310
+29,025
| +1% | +$1.13M | 0.78% | 60 |
|
|
2019
Q1 | $82.9M | Sell |
2,145,285
-445,595
| -17% | -$15.1M | 0.72% | 63 |
|
|
2018
Q4 | $73.8M | Buy |
2,590,880
+198,300
| +8% | +$6.3M | 0.75% | 59 |
|
|
2018
Q3 | $93.6M | Sell |
2,392,580
-23,580
| -1% | -$872K | 0.83% | 55 |
|
|
2018
Q2 | $78.1M | Sell |
2,416,160
-174,170
| -7% | -$4.79M | 0.76% | 60 |
|
|
2018
Q1 | $56.8M | Buy |
2,590,330
+336,975
| +15% | +$8.1M | 0.61% | 76 |
|
|
2017
Q4 | $53.4M | Buy |
2,253,355
+396,145
| +21% | +$9.99M | 0.6% | 77 |
|
|
2017
Q3 | $52.3M | Buy |
1,857,210
+55,448
| +3% | +$1.69M | 0.62% | 73 |
|
|
2017
Q2 | $58.1M | Buy |
1,801,762
+59,477
| +3% | +$1.81M | 0.71% | 67 |
|
|
2017
Q1 | $49.3M | Buy |
1,742,285
+89,010
| +5% | +$2.36M | 0.65% | 73 |
|
|
2016
Q4 | $40M | Buy |
1,653,275
+209,190
| +14% | +$5.13M | 0.55% | 86 |
|
|
2016
Q3 | $34.3M | Sell |
1,444,085
-69,605
| -5% | -$1.52M | 0.52% | 85 |
|
|
2016
Q2 | $27.8M | Sell |
1,513,690
-265,425
| -15% | -$4.15M | 0.48% | 91 |
|
|
2016
Q1 | $18.4M | Sell |
1,779,115
-183,195
| -9% | -$1.86M | 0.33% | 111 |
|
|
2015
Q4 | $29.7M | Buy |
1,962,310
+1,317,519
| +204% | +$19.6M | 0.51% | 88 |
|
|
2015
Q3 | $10.2M | Buy |
+644,791
| New | +$16.3M | 0.18% | 119 |
|
Other funds holding CSII
Champlain Investment Partners's CSII Position: Q2 2023 in Review
Champlain Investment Partners sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 2,301,475 shares — an estimated $45.7M sold.
Champlain Investment Partners first reported a position in CSII in Q3 2015 and held it in 31 quarters. The position peaked at $146M in Q2 2021. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.
- Champlain Investment Partners reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
- Champlain Investment Partners sold 2,301,475 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $45.7M.
- Champlain Investment Partners first reported a position in Cardiovascular Systems, Inc. in Q3 2015 and held it in 31 quarters.
- Champlain Investment Partners's Cardiovascular Systems, Inc. position peaked at $146M in Q2 2021.
- 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.
Based on Champlain Investment Partners's 13F filing for Q2 2023, filed 11 Aug 2023.